Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis
NCT00004682
·
clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Myasthenia Gravis
Interventions
DRUG:
immune globulin
Sponsor
University of Texas